[
  {
    "ts": null,
    "headline": "Merck (MRK) Declines More Than Market: Some Information for Investors",
    "summary": "Merck (MRK) closed the most recent trading day at $87.61, moving 1.34% from the previous trading session.",
    "url": "https://finnhub.io/api/news?id=a4a3b432fd8e93e836fcac23b2f3d1366c51207d951e34c354b39cd98ca981f3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759873802,
      "headline": "Merck (MRK) Declines More Than Market: Some Information for Investors",
      "id": 137008022,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Merck (MRK) closed the most recent trading day at $87.61, moving 1.34% from the previous trading session.",
      "url": "https://finnhub.io/api/news?id=a4a3b432fd8e93e836fcac23b2f3d1366c51207d951e34c354b39cd98ca981f3"
    }
  },
  {
    "ts": null,
    "headline": "Merck & Co. Inc. stock underperforms Tuesday when compared to competitors",
    "summary": "Merck & Co. Inc. stock underperforms Tuesday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=f664e53bc28ba0d6489da986130b246045f065b869e55eb2e891c61d27a4144d",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759854840,
      "headline": "Merck & Co. Inc. stock underperforms Tuesday when compared to competitors",
      "id": 137078235,
      "image": "",
      "related": "MRK",
      "source": "MarketWatch",
      "summary": "Merck & Co. Inc. stock underperforms Tuesday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=f664e53bc28ba0d6489da986130b246045f065b869e55eb2e891c61d27a4144d"
    }
  },
  {
    "ts": null,
    "headline": "How Arcus Biosciences Aims To Take On Merck In Cancer Treatment",
    "summary": "How Arcus Biosciences Aims To Take On Merck In Cancer Treatment",
    "url": "https://finnhub.io/api/news?id=1228af32a0b01a11b79283582e6059c36f04299fffc80b6f913d1977a851065c",
    "source": "DowJones",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759852990,
      "headline": "How Arcus Biosciences Aims To Take On Merck In Cancer Treatment",
      "id": 137015761,
      "image": "",
      "related": "MRK",
      "source": "DowJones",
      "summary": "How Arcus Biosciences Aims To Take On Merck In Cancer Treatment",
      "url": "https://finnhub.io/api/news?id=1228af32a0b01a11b79283582e6059c36f04299fffc80b6f913d1977a851065c"
    }
  },
  {
    "ts": null,
    "headline": "MRK Expands Tulisokibart Program in Three New Inflammatory Diseases",
    "summary": "Merck broadens its tulisokibart clinical program with three new phase IIb studies, deepening its reach across immune-mediated inflammatory diseases.",
    "url": "https://finnhub.io/api/news?id=20a3cb356afcc9fd863d3934668c2936f37e68ca847f6d5de4151b3d5d503c85",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759852560,
      "headline": "MRK Expands Tulisokibart Program in Three New Inflammatory Diseases",
      "id": 137002713,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Merck broadens its tulisokibart clinical program with three new phase IIb studies, deepening its reach across immune-mediated inflammatory diseases.",
      "url": "https://finnhub.io/api/news?id=20a3cb356afcc9fd863d3934668c2936f37e68ca847f6d5de4151b3d5d503c85"
    }
  },
  {
    "ts": null,
    "headline": "Gilead Resolves Patent Litigations for HIV Treatment Biktarvy",
    "summary": "Gilead's settlement on Biktarvy patents delays generic entry until 2036, boosting investor confidence.",
    "url": "https://finnhub.io/api/news?id=52323b6a612af2db7754cd17aa013e6e82899200a898aa2f67a55aaf4f8abce0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759844220,
      "headline": "Gilead Resolves Patent Litigations for HIV Treatment Biktarvy",
      "id": 136999032,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Gilead's settlement on Biktarvy patents delays generic entry until 2036, boosting investor confidence.",
      "url": "https://finnhub.io/api/news?id=52323b6a612af2db7754cd17aa013e6e82899200a898aa2f67a55aaf4f8abce0"
    }
  },
  {
    "ts": null,
    "headline": "Energy Robotics Secures $13.5 Million Series A to Scale Critical Infrastructure Inspections with AI + Robotics",
    "summary": "Energy Robotics, the leading AI software platform for autonomous inspection with robots and drones, today announced the successful close of $13.5m of Series A funding. Energy Robotics has completed over one million inspections across five continents, saving 32,000+ hours of hazardous human labor for customers across oil and gas, industrial, chemical, and utility sectors, including Shell, BP, Repsol, BASF, Merck and E.ON. This funding cements the company's position as a market leader of full-stac",
    "url": "https://finnhub.io/api/news?id=b1deee86a32e717ce54d4d8f09aeedfccf2de359e38f9de3437ce994a578989d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759842000,
      "headline": "Energy Robotics Secures $13.5 Million Series A to Scale Critical Infrastructure Inspections with AI + Robotics",
      "id": 136999033,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Energy Robotics, the leading AI software platform for autonomous inspection with robots and drones, today announced the successful close of $13.5m of Series A funding. Energy Robotics has completed over one million inspections across five continents, saving 32,000+ hours of hazardous human labor for customers across oil and gas, industrial, chemical, and utility sectors, including Shell, BP, Repsol, BASF, Merck and E.ON. This funding cements the company's position as a market leader of full-stac",
      "url": "https://finnhub.io/api/news?id=b1deee86a32e717ce54d4d8f09aeedfccf2de359e38f9de3437ce994a578989d"
    }
  },
  {
    "ts": null,
    "headline": "Merck Rises 13% in a Week: Should You Buy, Sell or Hold the Stock?",
    "summary": "MRK's stock witnesses an upside after Pfizer's pricing deal, but Gardasil's slump and Keytruda's looming LOE keep investors cautious.",
    "url": "https://finnhub.io/api/news?id=1abb297e6be03716f7053f6b96fee93e78e971ceb9e28854be00a15c20572caa",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759840020,
      "headline": "Merck Rises 13% in a Week: Should You Buy, Sell or Hold the Stock?",
      "id": 136998886,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "MRK's stock witnesses an upside after Pfizer's pricing deal, but Gardasil's slump and Keytruda's looming LOE keep investors cautious.",
      "url": "https://finnhub.io/api/news?id=1abb297e6be03716f7053f6b96fee93e78e971ceb9e28854be00a15c20572caa"
    }
  },
  {
    "ts": null,
    "headline": "Top Dividend Stocks Featuring Artisan Partners Asset Management",
    "summary": "As the U.S. stock market continues to reach new heights, with the Nasdaq and S&P 500 posting record closing highs, investors are increasingly seeking opportunities that offer both growth potential and reliable income streams. In this vibrant economic landscape, dividend stocks stand out as a compelling choice for those looking to balance risk and reward while capitalizing on consistent returns.",
    "url": "https://finnhub.io/api/news?id=761a4083912f025af0e7e5ffe2c9a83a499e6e88b7cf43fdcc55dc557d037077",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759836702,
      "headline": "Top Dividend Stocks Featuring Artisan Partners Asset Management",
      "id": 136999036,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "As the U.S. stock market continues to reach new heights, with the Nasdaq and S&P 500 posting record closing highs, investors are increasingly seeking opportunities that offer both growth potential and reliable income streams. In this vibrant economic landscape, dividend stocks stand out as a compelling choice for those looking to balance risk and reward while capitalizing on consistent returns.",
      "url": "https://finnhub.io/api/news?id=761a4083912f025af0e7e5ffe2c9a83a499e6e88b7cf43fdcc55dc557d037077"
    }
  },
  {
    "ts": null,
    "headline": "Merck Completes Acquisition of Verona Pharma",
    "summary": "RAHWAY, N.J., October 07, 2025--Merck Completes Acquisition of Verona Pharma",
    "url": "https://finnhub.io/api/news?id=a65ad3cc9abe1b602fceb582e6e7dcab15516e0f52d8f6727097fcf4facc8808",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759833900,
      "headline": "Merck Completes Acquisition of Verona Pharma",
      "id": 136999037,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "RAHWAY, N.J., October 07, 2025--Merck Completes Acquisition of Verona Pharma",
      "url": "https://finnhub.io/api/news?id=a65ad3cc9abe1b602fceb582e6e7dcab15516e0f52d8f6727097fcf4facc8808"
    }
  },
  {
    "ts": null,
    "headline": "Hiltzik: There's much less than meets the eye in Trump's 'historic' drug price deal with Pfizer",
    "summary": "Trump and Pfizer said they reached a landmark deal to cut drug prices. Most Americans won't see a benefit, but Pfizer will.",
    "url": "https://finnhub.io/api/news?id=113c9d7b7c6d7d5f0dffdcebf18a23fdf8b2763619c818a2a17a708c1f2bcab0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759831200,
      "headline": "Hiltzik: There's much less than meets the eye in Trump's 'historic' drug price deal with Pfizer",
      "id": 136998824,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Trump and Pfizer said they reached a landmark deal to cut drug prices. Most Americans won't see a benefit, but Pfizer will.",
      "url": "https://finnhub.io/api/news?id=113c9d7b7c6d7d5f0dffdcebf18a23fdf8b2763619c818a2a17a708c1f2bcab0"
    }
  }
]